Michael P. Holsapple

A multi-laboratory evaluation of a common in vitro pepsin digestion assay protocol used in assessing the safety of novel proteins

Karluss Thomas, M. Aalbers, Gary A. Bannon et al. · Regulatory Toxicology and Pharmacology · 2004 · 279 citations

Protein Chemistry, Laboratory Protocol, Engineering +11

Mode of Action in Relevance of Rodent Liver Tumors to Human Cancer Risk

Michael P. Holsapple, H. C. Pitot, Samuel H. Cohen et al. · Toxicological Sciences · 2005 · 262 citations

Pathology, Tumor Biology, Human Cancer Risk +29

Research Strategies for Safety Evaluation of Nanomaterials, Part II: Toxicological and Safety Evaluation of Nanomaterials, Current Challenges and Data Needs

Michael P. Holsapple, William H. Farland, Timothy D. Landry et al. · Toxicological Sciences · 2005 · 248 citations · Full text

Nanoparticles, Engineering, Roundtable Discussion +21

Aryl Hydrocarbon Receptor-Dependent Suppression by 2,3,7,8-Tetrachlorodibenzo-p-dioxin of IgM Secretion in Activated B Cells

Courtney E. W. Sulentic, Michael P. Holsapple, Norbert E. Kaminski · Molecular Pharmacology · 1998 · 104 citations

Immunosuppression by polycyclic aromatic hydrocarbons: A structure-activity relationship in B6C3F1 and DBA/2 mice

Kimber L. White, Helen H. Lysy, Michael P. Holsapple · Immunopharmacology · 1985 · 98 citations

Inflammation, Immunotoxicology, Medicine +10